M Rudhardt

770 total citations
30 papers, 331 citations indexed

About

M Rudhardt is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Clinical Biochemistry. According to data from OpenAlex, M Rudhardt has authored 30 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Clinical Biochemistry. Recurrent topics in M Rudhardt's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Metabolism and Genetic Disorders (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). M Rudhardt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Metabolism and Genetic Disorders (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). M Rudhardt collaborates with scholars based in Switzerland. M Rudhardt's co-authors include J Fabré, C Regamey, J Fabre, L Balant, Pierre Dayer, B Cochet, Mónica Climente Martí, Anne‐Françoise Allaz, Renato L. Galeazzi and B. M. Frey and has published in prestigious journals such as Kidney International, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

M Rudhardt

27 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Rudhardt Switzerland	11	189	69	54	46	41	30	331
D Höffler Germany	11	265 1.4×	62 0.9×	85 1.6×	33 0.7×	70 1.7×	83	453
R. D. Foord United States	9	305 1.6×	61 0.9×	118 2.2×	44 1.0×	51 1.2×	15	493
R. A. Walstad Norway	12	178 0.9×	35 0.5×	97 1.8×	27 0.6×	60 1.5×	30	426
C. Randall Marchbanks United States	8	177 0.9×	38 0.6×	125 2.3×	22 0.5×	23 0.6×	11	337
M. Cesana Italy	12	109 0.6×	37 0.5×	121 2.2×	13 0.3×	48 1.2×	28	332
Dawn Harper United States	8	115 0.6×	50 0.7×	44 0.8×	49 1.1×	59 1.4×	9	375
R W Schultz United States	8	155 0.8×	84 1.2×	75 1.4×	23 0.5×	39 1.0×	9	377
Agneta K. Hurst United States	8	116 0.6×	26 0.4×	56 1.0×	12 0.3×	87 2.1×	13	385
J. D. Wolny United States	8	164 0.9×	29 0.4×	103 1.9×	13 0.3×	28 0.7×	11	341
Kenneth Josefsson Sweden	10	71 0.4×	30 0.4×	99 1.8×	20 0.4×	28 0.7×	22	348

Countries citing papers authored by M Rudhardt

Since Specialization

Citations

This map shows the geographic impact of M Rudhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Rudhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Rudhardt more than expected).

Fields of papers citing papers by M Rudhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Rudhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Rudhardt. The network helps show where M Rudhardt may publish in the future.

Co-authorship network of co-authors of M Rudhardt

This figure shows the co-authorship network connecting the top 25 collaborators of M Rudhardt. A scholar is included among the top collaborators of M Rudhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Rudhardt. M Rudhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodler, J, et al.. (1984). Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: Clinical and pathophysiological implications. European Journal of Clinical Pharmacology. 26(5). 609–612. 11 indexed citations

Dayer, Pierre, et al.. (1983). [Effect of various types of liver diseases on the behavior of cefoperazone].. PubMed. 113(49). 1860–3. 3 indexed citations

Cochet, B, et al.. (1981). Serum levels and urinary excretion of cefoperazone in patients with hepatic insufficiency. Infection. 9(S1). S37–S39. 13 indexed citations

Cochet, B, et al.. (1981). [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].. PubMed. 111(14). 502–8. 6 indexed citations

Cochet, B, et al.. (1981). Decreased extrarenal clearance of cefoperazone in hepatocellular diseases.. British Journal of Clinical Pharmacology. 11(4). 389–390. 9 indexed citations

Fabré, J, et al.. (1979). [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].. PubMed. 8(33). 2677–82. 3 indexed citations

Dayer, Pierre, et al.. (1979). [Pharmacokinetics of a new cephalosporin, cefoperazone].. PubMed. 109(50). 1999–2005. 14 indexed citations

Rudhardt, M & J Fabre. (1979). Behavior of Amikacin in Renal Parenchyma of Normal Rats and of Rats with Acute Obstructive Renal Insufficiency. The Nephron journals/Nephron journals. 24(6). 287–291. 2 indexed citations

Chauvin, J., et al.. (1978). Le comportement de la gentamicine dans le parenchyme renal. [Behavior of gentamicin in the kidney parenchyma. Studies on rats during and after treatment with therapeutic doses]. IRIS. 1 indexed citations

10.

Fabre, J, et al.. (1978). Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10. 53–62. 6 indexed citations

11.

Rudhardt, M, et al.. (1978). [Behavior of gentamicin in the kidney parenchyma. Studies on rats during and after treatment with therapeutic doses].. PubMed. 108(27). 1020–5. 5 indexed citations

12.

Rudhardt, M, et al.. (1977). [Pharmacokinetic effect of various antibiotics in the tissues].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(17). 589–97. 3 indexed citations

13.

Fabré, J, et al.. (1977). Pharmacokinetics of Ampicillin, Cephalothin and Doxycycline in Various Tissues of the Rat. Chemotherapy. 23(3). 129–141. 24 indexed citations

14.

Fabré, J, et al.. (1976). Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney International. 10(6). 444–449. 84 indexed citations

15.

Rudhardt, M, et al.. (1975). Behaviour of Doxycycline in the Tissues. Chemotherapy. 21(1). 8–18. 24 indexed citations

16.

Rudhardt, M, et al.. (1974). [Incidence of erythrocyte fragmentation in nephropathies].. PubMed. 104(5). 170–7. 1 indexed citations

17.

Fabré, J, et al.. (1967). Influence of renal insufficiency on the excretion of chloroquine, phenobarbital, phenothiazines and methacycline.. PubMed. 33(4). 307–16. 21 indexed citations

18.

Rudhardt, M, et al.. (1966). [Does micronization enhance the efficacy of saline diuretics? Galenic and clinical study of micronized and non-micronized cyclothiazide].. PubMed. 96(16). 542–6. 1 indexed citations

19.

Rudhardt, M, et al.. (1965). [Chronic lymphocytic leukemia followed by reticulosarcoma].. PubMed. 95(43). 1434–6. 1 indexed citations

20.

Rudhardt, M, et al.. (1961). Différenciation et dédifférenciation des cellules leucémiques. Acta Haematologica. 25(2). 121–125. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact